| | Class 2 Device Recall LeadCare |  |
| Date Initiated by Firm | May 19, 2005 |
| Date Posted | June 21, 2005 |
| Recall Status1 |
Terminated 3 on November 21, 2005 |
| Recall Number | Z-0914-05 |
| Recall Event ID |
32066 |
| 510(K)Number | K971640 |
| Product Classification |
Lead, Atomic Absorption - Product Code DOF
|
| Product | LeadCare Blood Lead Testing System Kits
Catalog Number: 70-2233 |
| Code Information |
Lot CA6 Expiration date 2/5/05 Lot CA7 Expiration date 2/06/05 Lot CA8 Expiration date 5/18/05 Lot CA9 Expiration date 10/5/05 Lot CCA Expiration date 12/11/05 Lot CCE Expiration date 6/17/06 Lot CCF Expiration date 7/11/06 Lot CCH Expiration date 7/12/06 |
| FEI Number |
1218996
|
Recalling Firm/ Manufacturer |
Esa Biosciences, Inc. 22 Alpha Rd Chelmsford MA 01824-4123
|
| For Additional Information Contact | harold Asp 978-250-7106 |
Manufacturer Reason for Recall | Lead test results may be reported lower than the actual value |
FDA Determined Cause 2 | Other |
| Action | ESA is notifying beginning 5/19/05 to Distributors and End Users by letter sent First Class Mail. Additionally Distributors may be notified by phone to ensure receipt of letter.
Customers will be asked to return product to ESA for destruction. A fax back form is included with the notification letter. Customers will fax back the number of Test Kits that they require replacement for. ESA will ship replacement kits and include a prepaid return shipping label for the customer to return defective kits to ESA.
|
| Quantity in Commerce | 14,760 test kits |
| Distribution | United States
Foreign: Mexico, Canada, Indonesia, Palestine, Kingdom of Saudi Arabia, Columbia, Switzerland, Romania, West Indies, Italy, Japan, Turkey, United Kingdom, Phillipines, Singapore, Jamaica, Uraguay, South Korea, Peru, Tanzia, South Africa, Quatar, Croatia, Zambia, China, Germany |
| Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
| 510(K) Database | 510(K)s with Product Code = DOF
|
|
|
|